Sign inGet started

Schafer Klaus

Insider CIK 1705904 · NASDAQ:ALT Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ALT Altimmune, Inc. A Award deriv2026-05-012026-05-0148,800— $048,800SEC↗
ALT Altimmune, Inc. A Award deriv2025-09-252025-09-2948,800— $048,800SEC↗
ALT Altimmune, Inc. A Award deriv2024-09-262024-09-3034,900— $034,900SEC↗
ALT Altimmune, Inc. A Award deriv2023-09-282023-09-2926,100— $026,100SEC↗
ALT Altimmune, Inc. A Award deriv2022-09-292022-09-3023,500— $023,500SEC↗
ALT Altimmune, Inc. M Exercise deriv2022-06-202022-06-2260— $00SEC↗
ALT Altimmune, Inc. M Exercise deriv2022-06-202022-06-2260— $00SEC↗
ALT Altimmune, Inc. M Exercise deriv2022-06-202022-06-22159— $00SEC↗
ALT Altimmune, Inc. M Exercise2022-06-202022-06-2260$2.40 $1448,960SEC↗
ALT Altimmune, Inc. M Exercise2022-06-202022-06-2260$2.40 $1449,179SEC↗
ALT Altimmune, Inc. M Exercise2022-06-202022-06-22159$2.40 $3829,119SEC↗
ALT Altimmune, Inc. A Award deriv2021-09-232021-09-2424,100— $024,100SEC↗
ALT Altimmune, Inc. P Buy2020-12-102020-12-112,000$11.99 $24.0K8,900SEC↗
ALT Altimmune, Inc. S Sale2020-11-122020-11-1310,150$9.91 $100.6K6,900SEC↗
ALT Altimmune, Inc. M Exercise deriv2020-09-242020-10-1616,850— $00SEC↗
ALT Altimmune, Inc. M Exercise2020-09-242020-10-1616,850— $017,050SEC↗
ALT Altimmune, Inc. A Award deriv2020-09-242020-09-2825,500— $025,500SEC↗
ALT Altimmune, Inc. C Conversion deriv2020-06-252020-06-2916,850— $016,850SEC↗
ALT Altimmune, Inc. A Award deriv2019-01-022019-01-0420,000— $020,000SEC↗
ALT Altimmune, Inc. A Award deriv2017-10-132017-10-1720,000— $020,000SEC↗
NASDAQ:ALT Altimmune, Inc. A Award deriv2017-05-042017-05-084,775— $04,775SEC↗
NASDAQ:ALT Altimmune, Inc. A Award deriv2017-05-042017-05-081,791— $01,791SEC↗
NASDAQ:ALT Altimmune, Inc. A Award deriv2017-05-042017-05-081,791— $01,791SEC↗
NASDAQ:ALT Altimmune, Inc. A Award deriv2017-05-042017-05-081,791— $01,791SEC↗
NASDAQ:ALT Altimmune, Inc. A Award2017-05-042017-05-085,998— $05,998SEC↗